News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Karl Semaan received the Outstanding Research Award at KCRS24
Karl Semaan/X
Jul 15, 2024, 06:31

Karl Semaan received the Outstanding Research Award at KCRS24

Sylvan Baca, GU oncologist and computational epigenomics enthusiast at Dana-Farber Cancer Institute, shared on X:

“Congratulations to Karl Semaan on his Outstanding Research Award at KCRS24! Well deserved for his research on blood biomarkers of sarcomatoid RCC that I believe will make a difference for patients.”

Karl Semaan

Source: Sylvan Baca/X

blood biomarkers cancer Dana-Farber Cancer Institute Karl Semaan KCRS24 Kidney CAN OncoDaily Oncology Outstanding Research Award RCC sarcomatoid RCC Sylvan Baca
Special Coverage
Societies
Dec 24, 2024, 17:10
2024 ASCO Election Results
Blog
Dec 24, 2024, 16:51
New Officer and Directors to Join Society of Surgical Oncology Board on 2025-2028 Term
Blog
Dec 24, 2024, 16:42
Relapsed head and neck squamous cell carcinoma unrelated to HPV infection
Blog
Dec 24, 2024, 16:39
The V Foundation's December Star award goes to Paul Chrisman
Blog
Dec 24, 2024, 16:33
NCI Division of Cancer Prevention - 6 valid screening tools for malnutrition risk identification in outpatient oncology settings
Blog
Dec 24, 2024, 16:17
Vivek Subbiah: The latest and greatest in cancer research in 2024
Blog
Dec 24, 2024, 16:14
Karen Knudsen: Only 1/3 of patients receive 1L treatment intensification with an AR pathway inhibitor and/or docetaxel
Blog
Dec 24, 2024, 16:13
Season's Greetings from SIOP Europe
Blog
Dec 24, 2024, 15:46
Mediamedic - SABCS 2024: Clinical Symposium on Dose Optimization and Regimen Design in Breast Oncology
Insight
Dec 24, 2024, 15:12
BGICC 2025: The 17th Breast, Gynecological and Immuno-oncology International Cancer Conference - Key People Part 2
Drugs
Dec 24, 2024, 14:29
Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma
Opinion
Dec 24, 2024, 14:25
Portia Smallbone: HCT in patients with MF and splanchnic vein thrombosis